Publication Date:
2014-01-30
Description:
Key Points Plasma concentrations of CXCL9 are elevated at the onset of cGVHD diagnosis, but not in patients with cGVHD for more than 3 months. Plasma concentrations of CXCL9 are impacted by immunosuppressive therapy.
Print ISSN:
0006-4971
Electronic ISSN:
1528-0020
Topics:
Biology
,
Medicine
Permalink